KEGG: bcq:BCQ_3166
BCQ_3166 is a UPF0316 family protein consisting of 182 amino acids found in Bacillus cereus. The protein has a UniProt ID of B9ISM3 and is characterized by its predominantly hydrophobic amino acid sequence, suggesting it may be a membrane-associated protein . Based on sequence analysis, the protein appears to have several transmembrane domains, particularly evident in the N-terminal region of the protein where several hydrophobic amino acid stretches form potential membrane-spanning regions .
Recombinant BCQ_3166 protein can be efficiently produced using heterologous expression in Escherichia coli. The full-length protein (amino acids 1-182) is typically expressed with an N-terminal histidine tag to facilitate purification . For optimal expression, the BCQ_3166 gene should be codon-optimized for E. coli expression systems. After expression, the protein can be purified using nickel affinity chromatography, taking advantage of the His-tag. The purified protein is typically supplied as a lyophilized powder with purity greater than 90% as determined by SDS-PAGE analysis .
For long-term storage, recombinant BCQ_3166 protein should be kept at -20°C to -80°C, with aliquoting necessary to avoid repeated freeze-thaw cycles that can compromise protein integrity . When preparing the protein for storage:
Store the lyophilized powder at -20°C/-80°C upon receipt
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (50% is recommended as standard)
Aliquot into smaller volumes to avoid repeated freeze-thaw cycles
For short-term use, working aliquots can be stored at 4°C for up to one week
The reconstitution buffer typically consists of a Tris/PBS-based buffer with 6% Trehalose at pH 8.0, which helps maintain protein stability .
To investigate the membrane topology of BCQ_3166, researchers should employ multiple complementary approaches:
Computational prediction methods:
Use transmembrane prediction algorithms (TMHMM, Phobius, HMMTOP)
Apply topology prediction software that integrates multiple algorithms
Perform hydrophobicity plots analysis
Experimental verification methods:
Cysteine scanning mutagenesis with membrane-impermeable thiol-reactive reagents
Protease protection assays with recombinant protein in reconstituted membrane systems
Fluorescence resonance energy transfer (FRET) analysis using strategically placed fluorophores
Based on the amino acid sequence, BCQ_3166 likely contains multiple transmembrane domains, with the N-terminal region (amino acids 1-50) showing particularly high hydrophobicity that suggests membrane insertion .
CRISPR/Cas9 genome engineering provides a powerful approach for studying BCQ_3166 function through gene knockout, point mutations, or tagging. The protocol involves the following methodological steps:
Design sgRNA targeting the BCQ_3166 gene with appropriate protospacer adjacent motif (PAM) sites
Create a plasmid containing Cas9, sgRNA, and donor DNA with homologous arms flanking the target site
Transform the plasmid into B. cereus using electroporation
Select transformants on medium with appropriate antibiotics (typically kanamycin at 25 μg/ml)
Induce Cas9 expression using mannose (0.4% final concentration)
Screen for successful mutants using PCR and DNA sequencing
For optimal results in B. cereus, researchers should prepare competent cells by growing bacteria in brain heart infusion broth supplemented with 0.5% glycerol (BHIG) and perform electroporation under specific conditions (typically 25 μF, 200 Ω, 2.5 kV) . This technique has shown high efficiency in B. cereus, with successful point mutations achieving up to 100% modification rates in small genomic regions .
For investigating protein-protein interactions involving BCQ_3166, researchers should consider these methodological approaches:
In vitro methods:
Pull-down assays using His-tagged BCQ_3166 as bait
Surface plasmon resonance (SPR) for kinetic analysis of binding
Isothermal titration calorimetry (ITC) for thermodynamic parameters
In vivo methods:
Bacterial two-hybrid system adapted for Bacillus species
Proximity-dependent biotin identification (BioID)
Co-immunoprecipitation followed by mass spectrometry
Cross-linking approaches:
Chemical cross-linking with membrane-permeable reagents
Photo-cross-linking with modified amino acids incorporated into BCQ_3166
When designing these experiments, researchers should account for BCQ_3166's membrane association by using appropriate detergents (such as n-dodecyl β-D-maltoside or digitonin) for extraction while maintaining native protein interactions .
The structure-function relationship of BCQ_3166 can be analyzed in comparison to other UPF0316 family proteins through multiple approaches:
Sequence alignment analysis: Multiple sequence alignment of BCQ_3166 with UPF0316 proteins from related species reveals conserved domains, particularly in the transmembrane regions. The amino acid sequence of BCQ_3166 (MLQALLIFVLQIIYVPILTIRTILLVKNQTRSAAAVGLLEGAIYIVSLGIVFQDLSNWMNIVAYVIGFSAGLLLGGYIENKLAIGYITYQVSLLDRCNELVDELRHSGFGVTVFEGEGINS IRYRLDIVAKRSREKELLEIINEIAPKAFMSSYEIRSFKGGYLTKAMKKRALMKKKDHHAS) shows distinctive hydrophobic N-terminal regions that are characteristic of this protein family .
Structural prediction: Homology modeling and ab initio structure prediction methods suggest that BCQ_3166 likely forms multiple membrane-spanning α-helices with connecting loops that may participate in protein-protein interactions or substrate binding.
Functional domain analysis: Conserved domains in the C-terminal region (amino acids 120-170) suggest potential roles in signaling or regulatory functions, particularly through the SIRYRLDI motif found in the sequence .
For experimental validation of structure-function relationships, site-directed mutagenesis targeting conserved residues followed by functional assays would provide critical insights into this poorly characterized protein family.
Purifying and crystallizing membrane-associated proteins like BCQ_3166 presents several methodological challenges:
Purification challenges:
Maintaining protein stability during solubilization from membranes
Selecting appropriate detergents that preserve native conformation
Preventing protein aggregation during concentration steps
Crystallization challenges:
Detergent micelle interference with crystal contacts
Inherent conformational flexibility of membrane proteins
Low expression yields limiting material availability
| Detergent | Critical Micelle Concentration | Recommended Concentration for BCQ_3166 | Advantages | Limitations |
|---|---|---|---|---|
| n-Dodecyl β-D-maltoside (DDM) | 0.17 mM | 0.05-0.1% | Mild, maintains protein stability | Large micelle size |
| n-Octyl glucoside (OG) | 23-25 mM | 0.5-1.0% | Small micelle size, easily removed | Less gentle, may destabilize |
| Digitonin | 0.5 mM | 0.1-0.5% | Very mild, good for complexes | Expensive, heterogeneous |
| LMNG | 0.01 mM | 0.01-0.05% | High stability, small micelles | Expensive, difficult to remove |
Recommended approaches for BCQ_3166 include lipid cubic phase crystallization or the use of newer technologies such as single-particle cryo-electron microscopy, which has revolutionized membrane protein structure determination by eliminating the need for crystals .
Comprehensive phenotypic assessment of BCQ_3166 knockout mutants requires multi-omics approaches and functional assays:
Transcriptomic analysis:
RNA-Seq to identify differentially expressed genes in knockout vs. wild-type strains
RT-qPCR validation of key gene expression changes
Proteomic and metabolomic approaches:
Quantitative proteomics using iTRAQ or TMT labeling
Untargeted metabolomics to identify altered metabolic pathways
Lipidomics to assess membrane composition changes
Functional phenotypic assays:
Growth kinetics under various stress conditions (pH, temperature, osmotic stress)
Membrane permeability assessments using fluorescent dyes
Biofilm formation capacity evaluation
Motility assays (if applicable to the strain)
For genotypic verification of the knockout, researchers should employ PCR-based methods similar to those described for CRISPR/Cas9 genome engineering in B. cereus, where multiple primer pairs are used to confirm successful gene modification . The absence of BCQ_3166 expression can be confirmed by Western blotting using antibodies against the native protein or by RT-qPCR to verify the absence of transcript.
To ensure reproducible results when working with recombinant BCQ_3166, implement these quality control measures:
Protein purity assessment:
Size exclusion chromatography to assess aggregation state
Mass spectrometry to confirm protein identity and detect modifications
Functional assessment:
Circular dichroism spectroscopy to verify proper secondary structure
Activity assays (if known function) or binding assays
Thermal shift assays to assess protein stability
Storage stability monitoring:
Regular testing of aliquots to assess degradation over time
Freeze-thaw testing to determine sensitivity to temperature cycling
Documentation of lot-to-lot variation for commercial preparations
For consistent results, maintain strict temperature control during storage (-20°C/-80°C), avoid repeated freeze-thaw cycles, and use proper reconstitution procedures with deionized sterile water and glycerol addition as previously described .
When applying CRISPR/Cas9 for BCQ_3166 gene editing in B. cereus, researchers may encounter several challenges:
Solution: Optimize electroporation conditions (25 μF, 200 Ω, 2.5 kV) and use brain heart infusion broth with 0.5% glycerol (BHIG) for competent cell preparation
Recommendation: Use freshly prepared competent cells and ensure proper plasmid quality
Solution: Carefully design sgRNAs with minimal off-target potential using prediction tools
Recommendation: Sequence multiple locations with predicted off-target activity
Solution: Passage mutant strains multiple times (typically three) in the absence of antibiotics
Recommendation: Confirm plasmid loss by testing for kanamycin susceptibility
Solution: Ensure homology arms are at least 500-1000 bp in length
Recommendation: The B. cereus group has inherently low homologous recombination efficiency, so optimize donor DNA concentration and Cas9 expression timing
By addressing these challenges methodically, researchers can achieve high modification rates, as demonstrated in B. anthracis, where 100% modification rates were achieved for small genomic fragments using CRISPR/Cas9 .
Integrating BCQ_3166 function into systems biology models requires:
Contextual network analysis:
Integration of transcriptomic and proteomic data from BCQ_3166 mutants
Identification of co-expressed genes and protein interaction partners
Mapping BCQ_3166 to metabolic or signaling pathways
Regulatory network modeling:
Identification of transcription factors regulating BCQ_3166 expression
Characterization of BCQ_3166's response to environmental stressors
Integration into existing regulatory network models for B. cereus
Functional prediction refinement:
Machine learning approaches using multi-omics data
Evolutionary analysis across the Bacillus genus
Structural modeling integrated with omics data
The research pathway should begin with comprehensive phenotypic characterization of knockout mutants, followed by multi-omics data generation, and culminating in computational integration with existing B. cereus systems models. This approach could reveal unexpected functional roles for this poorly characterized protein and establish its context within bacterial physiology.
Understanding BCQ_3166 function could lead to novel applications in:
Pathogenesis intervention:
If BCQ_3166 plays a role in virulence, it could represent a new antimicrobial target
Development of inhibitors targeting BCQ_3166 function
Creation of attenuated B. cereus strains for vaccine development using precise CRISPR/Cas9 editing
Biotechnological applications:
Engineered B. cereus strains with modified BCQ_3166 for industrial applications
Development of biosensors if BCQ_3166 responds to specific environmental signals
Improvement of heterologous protein expression systems in Bacillus species
Ecological insights:
Understanding BCQ_3166's role in environmental adaptation
Potential involvement in biofilm formation or persistence
Contribution to B. cereus survival in food production environments
The CRISPR/Cas9 system described for B. cereus provides an excellent platform for precise genetic manipulation to explore these possibilities, allowing for marker-free mutations and even point mutations with high efficiency .
Comparative analysis of BCQ_3166 with homologous proteins in related Bacillus species reveals important functional insights:
Sequence conservation patterns:
BCQ_3166 shares significant sequence homology with proteins in B. anthracis and B. thuringiensis
Key conserved domains suggest shared functional roles across the B. cereus group
Species-specific variations may relate to pathogenic differences
Functional context differences:
In B. anthracis, homologous proteins may interact with virulence factors under PlcR regulation
The PlcR regulator is non-functional in B. anthracis due to a nonsense mutation at position 640, forming a stop codon, which affects the expression of many genes
B. thuringiensis homologs may have specialized functions related to insecticidal properties
Expression pattern variations:
Differential expression under various growth conditions across species
Potential co-regulation with species-specific virulence factors
Response to environmental stressors may vary between species
For experimental validation of functional conservation, CRISPR/Cas9-mediated genome editing can be applied across these Bacillus species following similar protocols, as the technology has been demonstrated to work efficiently in both B. anthracis and B. cereus with modification rates approaching 100% for small genomic modifications .
Investigating BCQ_3166 protein interactions across cellular compartments can provide comprehensive functional insights:
Membrane-associated interactions:
Identify potential protein complexes within the membrane
Characterize interactions with other membrane proteins
Examine role in maintaining membrane integrity or permeability
Cytoplasmic interactions:
Study potential interactions with cytoplasmic regulatory proteins
Investigate associations with metabolic enzymes
Characterize any role in signal transduction
Extracellular interactions:
Assess potential interactions with secreted proteins
Examine role in biofilm formation
Investigate interactions with host factors (if pathogenesis-related)
| Cellular Compartment | Recommended Interaction Analysis Method | Expected Interaction Partners | Challenges |
|---|---|---|---|
| Membrane | Chemical cross-linking, BN-PAGE | Transporters, signaling proteins | Detergent solubilization |
| Cytoplasm | Co-immunoprecipitation, Y2H | Regulatory proteins, chaperones | Distinguishing direct vs. indirect |
| Extracellular | Surface plasmon resonance, ELISA | Secreted proteins, host factors | Protein stability in assay conditions |
For investigating these interactions, researchers can use tagged versions of BCQ_3166 created using the CRISPR/Cas9 genome editing system, which allows for precise modifications with high efficiency .
Optimizing recombinant BCQ_3166 for cryo-EM structural studies requires:
Expression and purification optimization:
Screening multiple expression constructs with varying tags (His, MBP, SUMO)
Testing different E. coli expression strains (BL21(DE3), C41/C43 for membrane proteins)
Purification in appropriate detergents that maintain structural integrity
Sample preparation considerations:
Detergent exchange to amphipols or nanodiscs for improved particle dispersion
Concentration optimization to achieve 0.5-5 mg/ml without aggregation
Grid preparation with optimal ice thickness (use Quantifoil R1.2/1.3 or UltrAuFoil grids)
Data collection parameters:
Use of energy filters and K3/K2 direct electron detectors
Collection of large datasets (>5000 micrographs) to ensure sufficient particles
Implementation of motion correction and CTF estimation algorithms
For the specific case of BCQ_3166, its relatively small size (182 amino acids) presents challenges for cryo-EM, which typically works better for proteins >100 kDa. Consider using approaches such as antibody fragment complexing or reconstitution into nanodiscs to increase effective particle size and improve orientation distribution during imaging .
Designing BCQ_3166 constructs for functional complementation studies requires careful consideration:
Expression control elements:
Select promoters that match native expression levels (constitutive vs. inducible)
Include native regulatory elements if expression timing is critical
Consider integration location in the genome to avoid positional effects
Protein tagging strategy:
C-terminal tags are preferable for membrane proteins with N-terminal signal sequences
Use small tags (FLAG, HA) to minimize functional interference
Include flexible linkers (GGGGS repeats) between the protein and tag
Construct validation approaches:
Sequence verification to confirm construct integrity
Expression level testing using quantitative Western blotting
Localization confirmation using fluorescent tags or fractionation
For complementation studies in B. cereus, researchers should follow the transformation protocol using electroporation as described for CRISPR/Cas9 genome engineering, with selection on kanamycin (25 μg/ml) and appropriate induction of expression using systems compatible with B. cereus physiology .
When conducting functional studies with BCQ_3166 mutant strains, include these essential controls:
For knockout studies:
Wild-type parent strain (positive control)
Complemented mutant (knockout with restored BCQ_3166 expression)
Control knockout of unrelated gene to assess general effects of genetic manipulation
Multiple independent knockout clones to rule out off-target effects
For overexpression studies:
Empty vector control (same vector backbone without BCQ_3166 gene)
Strains expressing unrelated protein at similar levels
Dose-response with varying expression levels
Time-course studies to capture transient effects
Validation approaches:
RT-qPCR to confirm transcript absence/overexpression
Western blotting to verify protein levels
Phenotypic rescue experiments for knockouts
Whole genome sequencing to rule out secondary mutations
When creating knockout strains using CRISPR/Cas9, use multiple primer pairs for verification as demonstrated in the B. anthracis studies, where various primer combinations were used to confirm successful gene modifications .
Verifying BCQ_3166 subcellular localization requires multiple complementary approaches:
Biochemical fractionation methods:
Membrane isolation through differential centrifugation
Sequential extraction with increasing detergent strengths
Density gradient separation of membrane fractions
Western blot analysis of fractions using anti-BCQ_3166 antibodies
Microscopy-based approaches:
Fusion proteins with fluorescent tags (GFP, mCherry) for live-cell imaging
Immunofluorescence microscopy using fixed cells and specific antibodies
Super-resolution microscopy (STORM, PALM) for precise localization
Correlative light and electron microscopy for ultrastructural context
Control proteins for co-localization:
Known membrane proteins (positive controls)
Cytoplasmic proteins (negative controls)
Proteins with similar predicted topology
Given BCQ_3166's predicted membrane association based on its hydrophobic amino acid sequences, particular attention should be paid to membrane fractionation methods and proper controls to distinguish between different membrane compartments in B. cereus .